Sign Up to like & get recommendations! 0
Published in 2019 at "World neurosurgery"
DOI: 10.1016/j.wneu.2018.09.137
Abstract: OBJECTIVE The endoscopic technique is in many cases the technique of choice for the removal of pituitary adenomas. Extended endoscopic approaches make it possible to remove lesions with suprasellar and parasellar extension and fibrous consistency.… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Journal of veterinary internal medicine"
DOI: 10.1111/jvim.16724
Abstract: BACKGROUND Radiotherapy (RT) is an effective treatment for dogs presented with neurologic signs caused by pituitary tumors. However, its impact on the outcome of concurrent pituitary-dependent hypercortisolism (PDH) is controversial. OBJECTIVES Determine whether dogs with… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Endocrine connections"
DOI: 10.1530/ec-20-0414
Abstract: PURPOSE To evaluate whether pre-surgical treatment using long-acting somatostatin receptor ligands (SRL) may change pituitary tumor consistency and improve surgical outcome in GH-secreting pituitary macroadenomas. METHODS Retrospective study of 40 patients with GH-secreting pituitary macroadenomas… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Endocrine Connections"
DOI: 10.1530/ec-20-0434
Abstract: Introduction and aim It is difficult to distinguish between non-functioning pituitary macroadenomas (NFPMAs) and sellar meningiomas because of their overlapping imaging manifestations on routine MRI, especially in cases of meningiomas growing into the saddle. Here,… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "American Journal of Neuroradiology"
DOI: 10.3174/ajnr.a5735
Abstract: BACKGROUND AND PURPOSE: FOV optimized and constrained undistorted single-shot imaging provides relatively high-resolution images with few artifacts. This study evaluated the image quality and value of FOV optimized and constrained undistorted single-shot DWI in the… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2023.1098367
Abstract: Introduction Up to 5% of all pituitary tumors are hereditary e.g. due to MEN1 or aryl hydrocarbon receptor-interacting protein (AIP) genes mutations. Objectives The study was aimed at the assessment of the frequency and characteristics… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.813806
Abstract: Objectives A subset of non-functioning pituitary macroadenomas (NFMAs) may exhibit early progression/recurrence (P/R) after tumor resection. The purpose of this study was to apply deep learning (DL) algorithms for prediction of P/R in NFMAs. Methods… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cancers"
DOI: 10.3390/cancers11111658
Abstract: Background: Here, we compared the toxicity profiles of contemporary stereotactic radiosurgery (SRS), modern fractionated radiotherapy (FRT), and transsphenoidal surgery used to treat nonfunctioning pituitary macroadenomas. Methods: We included the data of patients with nonfunctioning pituitary… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Life"
DOI: 10.3390/life13010049
Abstract: To compare 7 T magnetic resonance imaging (MRI) of pituitary macroadenomas (PMA) with standard MRI and intraoperative findings regarding tumor detection, localization, size, and extension. Patients with suspected pituitary adenoma underwent pre-operative 1.5 T or… read more here.